A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease
Open Access
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 85 (2), 514-521
- https://doi.org/10.1016/0091-6749(90)90164-y
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Placebo-controlled Dose-Response Study of Enprofylline in the Maintenance Therapy of AsthmaAmerican Review of Respiratory Disease, 1989
- Life-threatening Theophylline Toxicity is Not Predictable by Serum LevelsChest, 1987
- Extrapulmonary effects of maintenance therapy with theophylline and inhaled albuterol in patients with chronic asthmaJournal of Allergy and Clinical Immunology, 1986
- Development of safer xanthine drugs for treatment of obstructive airways diseaseJournal of Allergy and Clinical Immunology, 1986
- Effects of enprofylline and theophylline may show the role of adenosineLife Sciences, 1986
- Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung diseaseEuropean Journal of Clinical Pharmacology, 1982
- Enprofylline, a Principally New Antiasthmatic XanthineActa Pharmacologica et Toxicologica, 1981
- Theophylline-Induced Seizures in AdultsAnnals of Internal Medicine, 1975
- Pharmacokinetic analysis of the effect of the ophylline on pulmonary function in asthmatic childrenThe Journal of Pediatrics, 1975
- Rational Intravenous Doses of TheophyllineNew England Journal of Medicine, 1973